Restasis
Allergan and St Regis Mohawk Tribe take patent ruling to Supreme Court
January 28, 2019Sales and Marketing Allergan, Mohawk, Restasis, St Regis, eye drops, patents
Allergan and the St Regis Mohawk Tribe have asked the Supreme Court to defend a 2017 patent agreement which would …
US court overturns Allergan’s controversial attempts to avoid Restasis patent review
July 23, 2018Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma
The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …
Rumours Allergan is looking to offload $5bn women’s health unit
April 3, 2018Manufacturing and Production, Sales and Marketing Allergan, Restasis, biotech, drugs, pharma, pharmaceutical
According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move …
Shire takes fight to Allergan over dry-eye drug
October 4, 2017Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical
It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …
New treatments to boost dry eye drug market – if approved
November 5, 2015Sales and Marketing Allergan, Ikervis, Restasis, Shire, cyclosporine, dry eye disease, dry eye syndrome, lifitegrast
The global market for treatments for dry eye syndrome will double in value to an estimated $4.6 billion by 2024, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
August 28, 2026
Agentis Health Group acquires Clinical Pharmacist Solutions
August 26, 2026
